(Q40689581)

English

Phase I study of atevirdine, a nonnucleoside reverse transcriptase inhibitor, in combination with zidovudine for human immunodeficiency virus type 1 infection. ACTG 199 Study Team

scientific article published on February 1995

Statements

Phase I study of atevirdine, a nonnucleoside reverse transcriptase inhibitor, in combination with zidovudine for human immunodeficiency virus type 1 infection. ACTG 199 Study Team (English)
Reichman RC
Morse GD
Demeter LM
Resnick L
Bassiakos Y
Para M
Powderly W
Leedom J
Greisberger C
1 February 1995
171
297-304

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit